132 related articles for article (PubMed ID: 11511836)
1. The penetration of 0.005% fluticasone propionate ointment in eyelid skin.
Tan MH; Lebwohl M; Esser AC; Wei H
J Am Acad Dermatol; 2001 Sep; 45(3):392-6. PubMed ID: 11511836
[TBL] [Abstract][Full Text] [Related]
2. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas.
Lebwohl MG; Tan MH; Meador SL; Singer G
J Am Acad Dermatol; 2001 Jan; 44(1):77-82. PubMed ID: 11148481
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone propionate in the treatment of inflammatory dermatoses.
Chu AC; Munn S
Br J Clin Pract; 1995; 49(3):131-3. PubMed ID: 7779663
[TBL] [Abstract][Full Text] [Related]
4. [Fluticasone propionate, corticosteroid for topical treatment].
Neumann E; Raszeja-Kotelba B
Pol Merkur Lekarski; 1998 Feb; 4(20):92-3. PubMed ID: 9591441
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
6. The effects of fluticasone propionate on nasal epithelial potential difference.
Graham SM; Scott SN; Launspach J; Zabner J
Am J Rhinol; 2002; 16(3):145-9. PubMed ID: 12141771
[TBL] [Abstract][Full Text] [Related]
7. Fluticasone propionate: safety profile.
Johnson M
Cutis; 1996 Feb; 57(2 Suppl):10-2. PubMed ID: 8646863
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases.
Roeder A; Schaller M; Schäfer-Korting M; Korting HC
Skin Pharmacol Physiol; 2005; 18(1):3-11. PubMed ID: 15608497
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of fluticasone propionate on IL-13 production by mitogen-stimulated lymphocytes.
Di Lorenzo G; Pacor ML; Pellitteri ME; Gangemi S; Di Blasi P; Candore G; Colombo A; Lio D; Caruso C
Mediators Inflamm; 2002 Jun; 11(3):187-90. PubMed ID: 12137248
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis.
Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG
Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103
[TBL] [Abstract][Full Text] [Related]
11. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
12. Topical corticosteroids in clinical practice: focus on fluticasone propionate.
Piacquadio DJ
Cutis; 1996 Feb; 57(2 Suppl):4-9. PubMed ID: 8646869
[TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone (cortisol) concentration and penetration gradient.
Kranz G; Schaefer H; Zesch A
Acta Derm Venereol; 1977; 57(3):269-73. PubMed ID: 71836
[TBL] [Abstract][Full Text] [Related]
14. A transgenic mouse model provides a novel biological assay of topical glucocorticosteroid potency.
Katchman SD; Del Monaco M; Wu M; Brown D; Hsu-Wong S; Uitto J
Arch Dermatol; 1995 Nov; 131(11):1274-8. PubMed ID: 7503571
[TBL] [Abstract][Full Text] [Related]
15. An open-label study of the safety and efficacy of limited application of fluticasone propionate ointment, 0.005%, in patients with atopic dermatitis of the face and intertriginous areas.
Tan MH; Meador SL; Singer G; Lebwohl MG
Int J Dermatol; 2002 Nov; 41(11):804-9. PubMed ID: 12453011
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone propionate: a rare contact sensitizer.
Goossens A; Huygens S; Matura M; Degreef H
Eur J Dermatol; 2001; 11(1):29-34. PubMed ID: 11174134
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the degree of dispersion and of the type of ointment base on the skin absorption of hydrocortisone and prednisolone ointments].
Skripkin IuK; Dobrotvorskiĭ AE; Demidova NM; Aliushin MT
Vestn Dermatol Venerol; 1974 May; 48(5):19-21. PubMed ID: 4839253
[No Abstract] [Full Text] [Related]
18. Effect of various marine lipids on transdermal drug delivery--in vitro evaluation.
Loftsson T; Gunnarsdóttir T; Magnúsdóttir LM; Frioriksdóttir H; Guomundsdóttir TK; Olafsson JH; Haraldsson GG; Guomundsson G; Hjaltason B
Boll Chim Farm; 1997 Nov; 136(10):640-5. PubMed ID: 9528172
[TBL] [Abstract][Full Text] [Related]
19. [In vitro comparison of transdermal characteristics of xiaoyu ointment and xiaoyu plaster].
Zhu C; Peng L; Chen B; He Q; Wen Q
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1599-602. PubMed ID: 22007541
[TBL] [Abstract][Full Text] [Related]
20. Serum tryptase in allergic rhinitis: effect of cetirizine and fluticasone propionate treatment.
Bruno G; Andreozzi P; Bracchitta S; Graf U; Santangelo G; Zaino S; Gaston N
Clin Ter; 2001; 152(5):299-303. PubMed ID: 11794849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
